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Abstract 
Pili annulati is a rare autosomal dominant hair disorder clinically characterized by a pattern 
of alternating bright and dark bands of the hair, the bright bands appearing dark if observed 
by transmitted light. This pattern is due to the periodic occurrence of air-filled cavities along 
the hair cortex which scatter and reflect the light while precluding its transmission. A 
susceptibility region, including a possibly responsible Frizzled gene, has been mapped to the 
telomeric region of chromosome 12q, although a specific mutation has not been identified. 
The condition has sometimes been observed in concurrence with alopecia areata, and in this 
paper we report a case in whom the concomitant severe alopecia areata was associated with 
autoimmune thyroid disease and primary IgA deficiency – a quadruple complex which, to our 
knowledge, has never been previously described. The occurrence of multiple immune 
disorders in the same patient affected by pili annulati could represent a key to 
understanding the high prevalence of alopecia areata in this condition. Specifically, in 
individuals predisposed to autoimmune disease, the molecular alterations that cause the 
anatomical changes of pili annulati could prompt the immune response against the hair root 
that underlies alopecia areata. 
 
Introduction 
The designation pili annulati refers to a rare hair disorder characterized by 
alternating light and dark bands of the hair shafts which give them a shiny appearance. 
This feature is caused by the periodic occurrence of air-filled cavities along the hair 
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cortex, which scatter the light. The condition is transmitted with an autosomal 
dominant pattern whose susceptibility gene locus maps to the telomeric region of 
chromosome 12q. It has sometimes been observed in concurrence with alopecia areata, 
and in this paper we report on a case of pili annulati in a 17-year-old patient with 
alopecia areata, autoimmune thyroid disease and primary IgA deficiency – a complex 
which, to our knowledge, has never been previously described in concomitance with 
pili annulati. A maternal aunt of the patient was affected by banded hair as well, but she 
did not suffer from any immunologic disorders.  
Clinical Case 
A 17-year-old girl presented with a 3-month history of alopecia areata, which had not responded 
to topical high-potency steroid therapy. The patient was affected by documented primary selective 
immunoglobulin A deficiency 1 (IgA D1) with recurrent respiratory and gastrointestinal infections 
dating from infancy. She had had stunted growth with menarche at the age of 15 and was 
considerably slight, with a height of 1.41 m and a weight of 39 kg, her height and weight parameters 
scoring below the third percentile. 
Dermatological examination revealed two large patches of hair loss at the scalp with angular 
contours and without signs of inflammation. The patches were localized at the vertex and the occipital 
region, respectively (fig. 1), the latter showing a typical pattern of ophiasis. Characteristic 
exclamation point hairs were present on their periphery. In addition, the patient’s uninvolved hair 
had a spangled appearance, due to a pattern of transverse bright and dark bands regularly alternating 
along the shafts and resulting in a striking ringed configuration of the single hairs (fig. 2). This feature 
had been present since infancy, looking more or less pronounced in the course of the patient’s life.  
The diagnosis of alopecia areata concurrent with pili annulati was issued and the subsequent 
determination of serum thyroid hormones and thyrotropin showed an increase of free T3, 
thyroglobulin and thyroid peroxidase, with remarkable reduction of thyroid-stimulating hormone 
(TSH), associated with high-titer antibodies for TSH receptor (TSH-R), thus revealing the presence of 
subclinical Graves’ disease. 
A banded pattern identical to the one observed in our patient was present in her 50-year-old 
maternal aunt’s hair, who was, however, not affected by any immunological disorder and was in 
generally good health. 
Laboratory investigation: Blood count, erythrocyte sedimentation rate and anti-streptolysin O 
antibody were normal. The determination of serum thyroid hormones and thyrotropin showed the 
following results: free T3: 4.470 pg/ml (normal: 2.00–4.400 pg/ml), TSH: 0.043 μIU/ml (normal: 
0.279–4.200 μIU/ml), anti-TSH-R antibodies: 5.0 IU/l (normal: 0.0–1.0 IU/l), anti-thyroglobulin 
antibodies: 800.30 IU/ml (normal: 100–115.00 IU/ml), and anti-thyroid peroxidase antibodies: 
586.30 IU/ml (normal 5.00–34.00). Serum IgA and Serum IgE levels were 6.5 mg/dl and 962 IU/ml, 
respectively. An array GCH test on peripheral lymphocytes did not show segmental aneuploidies. HLA 
serological typing showed A1, A2, B51, B18 Class I and DR8, DR14, DQ5 [1], DQ4 Class II phenotypes. 
Thyroid disease was treated with tiamazol in a dose of 5 mg/day. In regards to alopecia, in view of 
the patient’s immunodeficiency, the option of administering any systemic immunosuppressive 
therapy, either steroids, or cyclosporine, or infliximab, was discarded. Instead, after a further 
ineffective attempt with local steroids, local tacrolimus was chosen. In spite of the treatment, the hair 
loss progressed inexorably, and in the course of few months it extended to the whole scalp (fig. 3), to 
which, however, it remained localized, sparing the eyelashes, brows, and axillary hair. At the present 
time, a year after our first observation, alopecia totalis still persists with the same aforementioned 
clinical features. 
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Discussion 
Pili annulati (ringed hair) is a rare autosomal dominantly inherited abnormality of 
the hair, clinically characterized by a periodic pattern of light and dark bands (rings, if 
viewed in three-dimensional space) which impart the shafts a characteristic spangled 
appearance. If the hair is examined by transmitted light microscopy, the pattern is 
inverted and the regions seen as bright when viewed by the unaided eye or under a 
reflected light microscope appear dark. These biphasic bands result from the serial 
occurrence of clusters of air-filled cavities along the hair cortex whose uneven, keratin-
lined inner surface totally scatters and reflects the light, preventing it from being 
transmitted [1]. 
According to electron microscopic studies, these cavities seem to arise in the bulb as 
abnormal intracellular empty areas, initially filled with fluid material, which set apart 
otherwise morphologically normal keratin fibrils [2]. Correspondingly, the normal 
immunohistochemical expression of the common known cytokeratins in the altered 
hair shafts suggests that the changes are not caused by a structural defect of keratins, 
but by failure in the assembly of these or other structural proteins, which results in an 
insufficient formation of macrofibrils [3]. These hypothetical disorders of protein 
metabolism have been functionally related to the changes observed in the distribution 
of free ribosomes in the hair [4]. On the other hand, pathogenically significant 
alterations of the basement membrane zone have been observed in the region of the 
root, both with electron microscopy (reduplication of the lamina densa) and with 
immunohistochemistry (wavy basement membrane zone) [5]. 
Recently, a gene locus for pili annulati has been mapped through a linkage study to 
chromosome 12q24.32–24.33, with a critical interval of 3.9 Mb [6]. This interval was 
subsequently narrowed to a 2.9-Mb region on chromosome 12q24.33-ter, and its 
candidate genes were sequenced. However, no mutations possibly responsible for the 
condition were identified, either in the coding, or in the promoter sequences analyzed, 
a result suggesting that other, noncoding, regulatory elements, may be implied in the 
pathogenesis of ringed hair [7, 8]. It is interesting that the regions sequenced included 
the exons, but not the introns, of Frizzled 10 gene, whose product is the 
transmembrane receptor for Wnt proteins, and that, in another study, pili annulati has 
been reported as a possible phenotypic expression of nonsense Wnt mutations. This 
suggests that the changes could lie either in the receptor or in its ligand because of 
mutations in the still unexplored noncoding regions of Frizzled gene or in a coding 
region of Wnt gene, respectively [8, 9]. 
In our case, pili annulati was concomitant with alopecia areata, autoimmune thyroid 
disease and primary IgA deficiency. These three conditions have been frequently 
observed in association to each other but, out of the three, only alopecia areata has 
been found in coincidence with pili annulati [10–16]. Thus, to our knowledge, the 
simultaneous presence of pili annulati and more than one immunological disorder in 
the same patient is being reported for the first time in this paper. This occurrence is 
worthy of attention since it could shed light on the puzzling issue of a possible 
relationship between ringed hair and the immunologic disorder underlying alopecia 
areata. 
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Alopecia areata has been repeatedly described in patients with pili annulati, but 
studies performed on extended family pedigrees indicate that the two disorders are 
likely to occur independently of each other and thus they should be considered as 
coincidental, rather than associated [17, 18]. In fact, in spite of the significantly higher 
prevalence of alopecia areata in individuals affected by pili annulati in comparison to 
the general population, in none of the studied families could the concomitance of the 
two conditions be detected in more than one individual [18]. In addition, none of the 
known susceptibility loci for pili annulati corresponds either to the candidate region for 
alopecia areata detected through linkage studies or to the single nucleotide 
polymorphism-containing regions more recently identified through a genome-wide 
association study in this disorder [19–21]. 
Our observation seems to confirm this view, since out of two family members 
affected by pili annulati only one, i.e., the girl studied by us, suffered from 
immunological disorders. Yet, it cannot be excluded that, in pili annulati, genetically 
inscribed molecular, and thus, antigenic alterations of the hair root would make it 
prone to the autoimmune response underlying alopecia areata, if predisposing 
mutations of the immune system are present [19–21]. Consistently, the putative locus 
for pili annulati contains the gene Frizzled 10 [8], which is involved in development and 
organogenesis, whereas the regions significantly associated with alopecia areata 
contain genes controlling T cell-mediated immunity as well as genes expressed in the 
hair follicle [20, 21]. 
As far as the comorbidity alopecia areata/thyroid autoimmunity is concerned, it 
should be underlined that the thyroid disorder detected in our case was Graves’ 
disease, whereas the form usually reported is Hashimoto thyroiditis [10–22], the two 
conditions sharing only three genetic loci out of several candidate regions identified for 
them [23, 24]. However, a wide-ranging comparison between our case and the 
literature was precluded by the lack of data about the type of thyroid involvement in 
most statistical studies. 
Surprisingly, the patient’s HLA phenotype resulting from serological typing did not 
show any correspondence either with the haplotypes usually associated with alopecia 
areata or with the ones characteristic of autoimmune thyroid disease [14, 25]. GCH 
microarray, performed in consideration of the patient’s complex clinical situation, did 
not reveal any major genetic defect. 
In conclusion, the simultaneous presence of pili annulati and a complex of three 
immune disorders in the same patient reported in the present paper suggests that a 
coincidental as well as synergic combination of an autoimmune trait and 
molecular/antigenic changes of the hair bulb, induced by distinct genes with different 
locations, may represent a key to understanding the frequent concomitant occurrence 
of pili annulati and alopecia areata in the absence of common susceptibility loci. 
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Fig. 1. Aphlegmatic patch of alopecia with angular contours. 
 
 
 
Fig. 2. Hairs with a pattern of transverse bright and dark bands regularly alternating along the shafts. 
 
 
 
Fig. 3. Hair loss on the whole scalp. 
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